FOXO3 and Hyperglycemia: Additionally, RES treatment ameliorates renal function and glomerulosclerosis and increases SIRT1 deacetylase activity, subsequently decreasing the expression of acetylated FOXO3a and inhibiting the oxidative stress caused by hyperglycemia both in vivo and in vitro (Wang et al., 2017).